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Summary
Infection of Sulfolobus islandicus REY15A with mix-
tures of different Sulfolobus viruses, including STSV2,
did not induce spacer acquisition by the host CRISPR
immune system. However, coinfection with the tailed
fusiform viruses SMV1 and STSV2 generated hyperac-
tive spacer acquisition in both CRISPR loci, exclu-
sively from STSV2, with the resultant loss of STSV2 but
not SMV1. SMV1 was shown to activate adaptation
while itself being resistant to CRISPR-mediated adap-
tation and DNA interference. Exceptionally, a single
clone S-1 isolated from an SMV1 + STSV2-infected
culture, that carried STSV2-specific spacers and had
lost STSV2 but not SMV1, acquired spacers from
SMV1. This effect was also reproducible on reinfecting
wild-type host cells with a variant SMV1 isolated from
the S-1 culture. The SMV1 variant lacked a virion
protein ORF114 that was shown to bind DNA. This
study also provided evidence for: (i) limits on the
maximum sizes of CRISPR loci; (ii) spacer uptake
strongly retarding growth of infected cultures; (iii)
protospacer selection being essentially random and
non-directional, and (iv) the reversible uptake of
spacers from STSV2 and SMV1. A hypothesis is pre-
sented to explain the interactive conflicts between
SMV1 and the host CRISPR immune system.
Introduction
Clustered regularly interspaced short palindromic repeats
(CRISPR) provide the basis for diverse adaptive immune
systems common to most archaea and many bacteria. The
spacer regions derive from invading genetic elements and
are inserted into CRISPR loci commonly, but not invariably,
adjacent to the CRISPR leader. Generally transcripts are
initiated within the leader and are processed within repeats
to yield small crRNAs, carrying most or all of the individual
spacer sequences, which then act as guide RNAs for
diverse interference complexes that target and cleave
DNA or RNA (reviewed in Garrett et al., 2011; Makarova
et al., 2011; Terns and Terns, 2011; Wiedenheft et al.,
2012; Barrangou and van der Oost, 2013; Zhang et al.,
2013).
Although considerable progress has been made in
determining the different mechanisms of CRISPR RNA
processing and maturation, and in elucidating the struc-
tures and targeting modes of some of the different inter-
ference complexes, our understanding of the molecular
mechanisms involved in the adaptation process remains
minimal. Adaptation involves the selection of protospacers
on invading genetic elements and their insertion into
CRISPR loci and it appears to be the most conserved stage
of the adaptive immune response. It was first observed in
the laboratory for the bacterial-specific subtype II-Asystem
of Streptococcus thermophilus (Barrangou et al., 2007;
Deveau et al., 2008). Three proteins Cas1, Cas2 and
generally Cas4 have been implicated in this process,
although in the streamlined subtype I-E and I-F systems of
Escherichia coli lack Cas4, as do subtype II-A and some
subtype III-Asystems (Garrett et al., 2011; Makarova et al.,
2011). In the E. coli systems, the interference endonucle-
ase Cas3 may replace Cas4, a supposition that is sup-
ported by the coexpression of Cas1, Cas2 and Cas3 in
these systems, and by the interaction of Cas1 with a
Cas2-Cas3 hybrid protein in the subtype I-F system of
Pectobacterium atrosepticum (Richter et al., 2012). Cas1,
the largest and most conserved protein, exhibits DNA
endonuclease activity (Wiedenheft et al., 2009; Babu
et al., 2011) and its mutation in the E. coli subtype I-E
system can inhibit spacer acquisition (Yosef et al., 2012).
Cas2 protein from Bacillus halodurans also exhibits
dsDNA endonuclease activity (Nam et al., 2012) while
another Cas2 protein, from Sulfolobus solfataricus and
other archaea, shows low specificity ssRNA endonuclease
activity (Beloglazova et al., 2008). Cas4 of Sulfolobus sol-
fataricus carries 5′- to 3′-DNA exonuclease activity that
may generate recombigenic 3′-overlaps for CRISPR
spacer insertion (Zhang et al., 2012).
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Leaders were originally implicated, indirectly, in spacer
acquisition because, for S. solfataricus strains, CRISPR
loci lacking leaders did not accrue new spacers (Lillestøl
et al., 2006; 2009). Moreover, neighbour-joining trees pro-
vided support for the coevolution of Cas1 proteins, leaders
and CRISPR repeats, for members of the Sulfolobales,
consistent with their cofunctionality in spacer acquisition
(Shah et al., 2009; Shah and Garrett, 2011). More recently,
experimental evidence has demonstrated that at least part
of the 43 bp of the leader adjacent to the first CRISPR
repeat is essential for acquisition activity in an E. coli
subtype I-E system (Yosef et al., 2012; Díez-Villaseñor
et al., 2013).
In subtype I-A systems of the Sulfolobales initial proto-
spacer selection is highly specific, occurring one base
pair after the PAM sequence. However, recognition at
the other end of the protospacer shows no detectable
sequence specificity and, moreover, multiple recognition
sites can occur over up to six base pairs for a given
protospacer region in different copies of the same genetic
element (Erdmann and Garrett, 2012). These, and earlier
results on Sulfolobus species (Lillestøl et al., 2009) con-
trast with the recent finding of a potential motif down-
stream from the protospacer in E. coli (Yosef et al., 2013).
The S. solfataricus spacer acquisition results led to the
proposal that a ruler mechanism operates for protospacer
excision measured from the PAM sequence and this
hypothesis was reinforced by the observation that many
protospacers contain internal PAM sequences that can
also be recognized, independently, during the putative
protospacer excision from other intracellular copies of
the same genetic element (Erdmann and Garrett, 2012).
Experimental evidence for a second ruler mechanism
operating during spacer insertion into CRISPR loci was
provided for the E. coli subtype I-E system whereby initial
cleavage occurs at the leader-repeat junction with a sec-
ondary cut occurring at the other end of the first repeat
(Díez-Villaseñor et al., 2013). These authors propose,
further, that the occurrence of a dual ruler strategy during
the two main acquisition steps, protospacer excision and
spacer insertion, could ensure maintenance of the regular
periodicity within CRISPR loci.
Members of the Sulfolobales are hosts for a wide range
of viruses which exhibit greater morphological diversity
than those of bacteria (Prangishvili et al., 2006a; Pina
et al., 2011) and, moreover, single environmental isolates
often carry different viruses propagating stably within cells
(Prangishvili and Garrett, 2005). In addition, individual
species generally carry large and multiple CRISPR loci
and mixtures of type I and different type III interference
systems, some of which remain to be characterized func-
tionally (Garrett et al., 2011; Zhang et al., 2012; Deng
et al., 2013). The CRISPR spacers reflect this diversity by
showing multiple predicted sequence matches to charac-
terized viruses of the Sulfolobales exhibiting both linear
and circular DNA genomes (Lillestøl et al., 2006; 2009;
Shah et al., 2009; 2011; Shah and Garrett, 2011).
Earlier, we showed that on infecting S. solfataricus P2
cells with an environmental virus mixture, sampled from
Yellowstone National Park, USA, that contained a single-
tailed fusiform Sulfolobus virus and a minor conjugative
plasmid component, later labelled Sulfolobus monocauda-
virus SMV1 and pMGB1 respectively (Erdmann et al.,
2013), hyperactive spacer acquisition occurred exclusively
from the plasmid (Erdmann and Garrett, 2012). Moreover
the acquisition occurred in different CRISPR loci by two
distinct mechanisms; in two loci, spacers were inserted
adjacent to the leaders and in a third locus, spacers were
incorporated throughout a single CRISPR array (Erdmann
and Garrett, 2012). Here we examine further these unusual
effects of SMV1 on different Sulfolobus viruses and the
exceptional influence of SMV1 on CRISPR immune
systems of S. islandicus REY15A for which a range of
genetic tools are now available (Deng et al., 2009; Peng
et al., 2009).
Results
Infection of an S. islandicus culture with the
tailed-fusiform virus SMV1 leads to cell death
S. islandicus REY15A carries two CRISPR loci containing
115 and 93 spacer-repeat units, a single gene cassette
encoding proteins Cas1, Cas2 and Cas4, implicated in
spacer acquisition, a single gene for the CRISPR RNA
processing enzyme Cas6, and one cas gene cassette for
a subtype I-A DNA interference system, as well as two
cmr gene cassettes encoding subtype III-B interference
complexes (Guo et al., 2011; Deng et al., 2013). The
CRISPR loci are coupled to the subtype I-A cas genes
and are illustrated schematically in Fig. 1.
S. islandicus was tested initially for infectivity with an
enriched virus mixture from Yellowstone National Park
containing the tailed-fusiform virus SMV1 as a major com-
L115 csa1 csa3
Locus 1 Locus 2
cas1 cas2 cas4 L 93 csa3 csa5 csa2 cas5 cas3 casHD csaX cas6
adaptation interference
Fig. 1. Schematic representation of the CRISPR loci 1 and 2 of S. islandicus and the associated cas genes. The gene clusters implicated in
spacer acquisition (adaptation) and in DNA interference are marked. The number of spacer-repeat units is given for each CRISPR locus and L
denotes the leader regions.
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ponent, a rod-shaped virus, and the conjugative plasmid
pMGB1 as a very minor component (Erdmann and
Garrett, 2012; Erdmann et al., 2013). Growth retardation
of the culture occurred 15–17 days post infection (p.i.)
(Fig. 2A) and electron micrographs of sample superna-
tants taken 15 days p.i. revealed the exclusive presence
of single-tailed fusiform particles similar in size and form
to SMV1 (Fig. 2B). The particles were purified by density
gradient centrifugation and the dsDNA genome was
sequenced. The sequence matched precisely to DNA
contig sequences of the virus propagated earlier in S. sol-
fataricus P2 (Erdmann and Garrett, 2012) and, further,
yielded a circular genome.
We demonstrated by PCR amplification that SMV1, but
not pMGB1, was present in the culture over 30 days p.i.
(Fig. 3A). This occurred despite the presence of a match
between spacer 87 of CRISPR locus 1 and an IS element
in SMV1 (positions 25475–25515 with a single mismatch
at position 25477). A high number of mismatches are
tolerated by the CRISPR DNA interference machinery in
both S. solfataricus and S. islandicus (Gudbergsdottir
et al., 2011; Manica et al., 2011; 2013).
In earlier work, activation of spacer acquisition coincided
with the onset of growth retardation of an SMV1 + pMGB1-
infected S. solfataricus culture (Erdmann and Garrett,
2012). Therefore, CRISPR loci 1 and 2 of SMV1-infected
S. islandicus were screened for the presence of new
spacers over a 30 day period p.i. In both CRISPR loci,
regions covering part of the leader and the first four repeat-
spacer units were amplified by PCR (Table S1) but no
larger products were formed consistent with a lack of de
novo spacers. Instead, the main PCR products from the
two leader-adjacent regions decreased dramatically in
yield and they were no longer detectable at 30 days p.i. for
both loci (Fig. 3B). This correlates approximately with the
absence of PCR-amplified products from a core protein of
S. islandicus (YP_005647721.1) 25 days p.i. (Table S1;
Fig. 3A). We inferred that the infected host cells were being
destroyed.
Properties of SMV1
Virions of SMV1 are fusiform (averaging 200 × 70 nm)
with a single tail varying in length from 20 to 250 nm and
B
Time [h]
A
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+SMV1
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Fig. 2. S. islandicus infected with the SMV1 isolate from Yellowstone National Park, USA.
A. Growth curves of uninfected and SMV1-infected cultures measured over 18 days p.i.
B. Electron micrographs of virus-like particles isolated 15 days p.i. from the infected culture.
1
2
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Fig. 3. Infection of S. islandicus with purified SMV1.
A. PCR-amplified products from SMV1 and a core gene
(YP_005647721.1) of S. islandicus, S.isl. The control samples (C)
are purified SMV1 (upper lane) and the core gene of uninfected
S. islandicus (lower lane). Dpi, days post infection.
B. PCR-amplified products from leader proximal regions of CRISPR
loci 1 and 2 for SMV1-infected S. islandicus and an uninfected
control (C). PCR priming sites are listed in Table S1.
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a nose-like structure on the opposite pole (Fig. 2B), which
in rare cases extended to generate a short second tail. On
infection growth retardation occurs concurrently with virus
replication, but no evidence was found for cell lysis upon
virion release. No clear plaques were seen on Gelrite
plates, nor was cell debris visible in infected cultures.
Seven protein bands were resolved from the purified
virions by gel electrophoresis with a major component of
about 18 kDa (Fig. S1A).
The dsDNA sequence of the purified virus was deter-
mined by high throughput sequencing and there was
sequence identity with the few contigs generated in the
earlier study, covering about 74% of the genome which
established that it was the same virus (Erdmann and
Garrett, 2012). Restriction enzyme digestion of the viral
DNA using a range of enzymes revealed normal digestion
patterns with no evidence for base-specific modifications
(Fig. S1B). Moreover, no evidence was found for integra-
tion in the host genome. The circular genome of 48 775 bp
carries 51 annotated protein genes, 25 of which are
arranged in nine operons. Sequence comparisons with
public sequence databases established that 14 of the
predicted gene products are homologous with proteins
encoded by the Acidianus two-tailed virus ATV (Häring
et al., 2005; Prangishvili et al., 2006b; Scheele et al., 2011)
with most of the remaining gene products yielding no
significant matches in public sequence databases. The
genome map is presented in Fig. 4 and details of the ATV
homologues and predicted protein functions, and their
e-values, are given in Table S2. The genome sequence is
available in the European Nucleotide Archive, Accession
Number HG322870.
Fig. 4. Circular genome map of SMV1. Locations of the 45 de novo spacers which matched to SMV1 DNA are shown in the inner and outer
concentric circles. Genes with predicted functions are shaded grey and are labelled. Full details of the SMV1 genomic properties are
presented separately in Table S2. The nucleotide sequence is available in the European Nucleotide Archive, Accession Number HG322870.
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Spacer acquisition on infection with SMV1 + STSV2
Earlier spacer acquisition in S. solfataricus was observed
only after infection with a mixture of SMV1 and a conju-
gative plasmid pMGB1 and not after infection with single
Sulfolobus viruses, including STSV2 (Erdmann and
Garrett, 2012; S.E., S.L.B., R.A.G., unpublished work).
STSV2 is a large single-tailed fusiform virus isolated from
the Tengchong region, China, with a circular genome of
76 107 bp that is modified (Erdmann et al., 2014). No
evidence was found for integration in the S. islandicus
genome. STSV2 infection only caused weak growth retar-
dation of S. islandicus consistent with the putative viral
release by a budding mechanism without causing cell
lysis (Erdmann et al., 2014). Therefore, in order to test
whether SMV1 coinfection could induce spacer acquisi-
tion from STSV2, the following S. islandicus cultures
were prepared: STSV2-infected, SMV1-infected, and
SMV1 + STSV2-infected, together with an uninfected
control culture. Growth retardation was only detected for
the SMV1-infected and SMV1 + STSV2-infected cultures,
both at 12 to 14 days p.i. (Fig. 5A). Leader proximal
regions of CRISPR loci 1 and 2 were then analysed for de
novo spacers by PCR amplification. Larger PCR frag-
ments, indicative of spacer uptake, were produced from
both loci only for the SMV1 + STSV2-infected culture
(Fig. 5B). These products were isolated and cloned, and
then sequencing of a fraction of the clones yielded 215 de
novo spacers sequences with up to 5 new spacers in
locus 1 and up to 8 new spacers in locus 2. They all
B
A
60
0
Time [h]
A
1
2
Dpi14 Dpi35Dpi25Loci
+STSV2
+SMV1
+STSV2 +  SMV1
uninfected
C
Fig. 5. Infection of S. islandicus with SMV1
and STSV2.
A. Growth curves of S. islandicus uninfected
and infected with SMV1 alone, STSV2 alone,
and a mixture of SMV1 + STSV2 over the
period 12–16 days p.i.
B. PCR products amplified from leader
proximal regions of CRISPR loci 1 and 2 after
infection with a mixture of SMV1 + STSV2,
and from an uninfected S. islandicus control
(C). Dpi, days post infection.
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matched exclusively to STSV2 and no sequence matches
were observed for SMV1.
Single colonies from the culture infected with
SMV1 + STSV2 were then isolated in order to determine
the numbers of spacers and their distributions between
the two CRISPR loci. In total 29 clones were analysed, 27
of which yielded unique de novo spacer patterns (Table 1
and Table S3). S-1, isolated 12 days p.i., exhibited single
new spacers in each CRISPR locus, nine clones (S-2 to
S-10) were selected 20 days p.i., four of which carried
new spacers in both loci. A further eighteen clones (S-11
to S-29) were analysed 30 days p.i and all except two
carried new spacers in both loci. On average there were
2.4 new spacers per clone 20 days p.i and 7 new spacers
per clone 30 days p.i consistent with spacer acquisition
being an ongoing process over the 30 day period
(Table 1). In total 141 new, unique, spacer sequences
were obtained from the single clones.
Next, in order to show that no undetected SMV1-
matching spacers were inserted internally in the CRISPR
arrays, both loci were screened for indels using PCR
primers annealing at about 750 bp intervals along
each locus (Fig. 1). DNA samples extracted from the
SMV1 + STSV2-infected wild-type culture at 10, 15, 25 and
40 days p.i. served as PCR templates. The product sizes
were consistent with neither spacer-repeat insertions nor
deletions having occurred in either CRISPR locus (data not
shown). Corresponding analyses of PCR products of both
CRISPR loci from each of the 27 unique clones (Table 1)
also revealed no significant size changes, in either locus,
except for three clones. In S-10, one new spacer matching
STSV2 was inserted between spacers 12 and 13 of locus
2; in S-35, the three spacers adjacent to the leader were
replaced by two de novo spacers each matching STSV2,
and in S-17 there was a large deletion of 2954 bp at the
leader distal end of locus 1. In summary, while both loci
appear to be quite stable on viral infection and during
spacer acquisition for most of the infected culture, a minor-
ity of cells undergo diverse structural changes in their
CRISPR loci.
Properties of de novo CRISPR spacers from STSV2
In total 347 new spacers were sequenced of which 29
were duplicated. The 318 unique sequences all matched
the STSV2 genome. Spacer lengths varied from 38 to
46 bp, with single outliers of 35 bp and 48 bp. They are
superimposed on the two DNA strands of the STSV2
genome in concentric circles (Fig. S2). The additional
outermost and innermost circles show the distributions
of CCN PAM sequences present in the genome. Several
of the STSV2 protospacers overlap and many share the
same end adjoining the PAM sequence but exhibit dif-
ferent lengths. The protospacers are distributed almost
equally between the two DNA strands (52.7% and
47.3%), and fairly evenly throughout the circular STSV2
genome (Fig. S2), consistent with earlier results
obtained for S. solfataricus on infection with a mixture of
SMV1 + pMGB1 (Erdmann and Garrett, 2012; Erdmann
et al., 2013). Moreover, they appear to be distributed
proportionally between protein genes and intergenic
regions. These constitute an estimated 89% and 11% of
the genome, respectively, and carry 85.7% and 14.3% of
the newly acquired protospacers respectively (Table 2).
There is also an equal distribution between the coding
and mRNA complementary strands of the protein genes
(43% and 42.7% respectively). With very few exceptions
the protospacers exhibit perfect sequence matches to
the de novo spacers.
We also examined the location and strand-specificity of
multiple spacers that were acquired per CRISPR locus in
single clones. The strand-specificity results are shown in
Table 1 where (+) following a de novo spacer indicates a
DNA forward strand match while (−) denotes a reverse
strand match. There is no evidence for a biased strand
directionality for successively acquired spacers in a given
Table 1. De novo spacers matching STSV2 identified in 27 unique
single clones of S. islandicus infected with SMV1 + STSV2.
Clone Locus 1 Locus 2
Dpi 12
S-1 1 (−) 1 (+)
Dpi 20
S-2 1 (+)
S-3 1 (+)
S-4 1 (+), 1 (−)
S-5 2 (+)
S-6 2 (−)
S-7/S-8 2 (+) 1 (−)
S-9 2 (+) 1 (+)
S-10 1 (+), 2 (−) 2 (+)
Dpi 30
S-11 1 (−)
S-12 3 (+)
S-13 2 (+) 1 (−)
S-14/S-15 1 (+), 2 (−) 1 (+)
S-16 1 (+) 2 (+), 1 (−)
S-17 1 (−) 3 (+), 1 (−)
S-18 1 (+), 1 (−) 2 (+), 2 (−)
S-19 3 (+) 3 (+)
S-20 1 (+), 1 (−) 3 (+), 1 (−)
S-21 2 (−), 1 (+) 3 (+)
S-22 1 (+), 1 (−) 4 (+), 1 (−)
S-23 1 (+), 3 (−) 7 (+)
S-24 2 (−) 2 (+), 4 (−)
S-25 3 (+), 3 (−) 2 (+)
S-26 3 (+), 2 (−) 2 (+), 3 (−)
S-27 3 (+), 2 (−) 5 (+), 3 (−)
S-29 2 (+), 3 (−) 4 (+), 4 (−)
(+) matching the forward and (−) matching the reverse strand on the
STSV2 genome. Spacer sequences are given in Table S3.
Dpi, days post infection when the clones were isolated.
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CRISPR locus of each clone, nor was there any evidence
for a close genomic linkage of successively acquired
spacers.
The PAM sequence CCN was conserved for 95.9% of
the protospacers, consistent with earlier analyses (Shah
et al., 2013). Moreover, analysis of the −1 position revealed
a strong and equal bias to A and T (39.3% and 38.4%
respectively) relative to G (11%) and C (7.3%) which
correlates approximately with the genomic bias of the 4816
predicted PAM sequences (A-35.5%, T-35.5%, C-17.7%
and G-11.3%) (Table 2). This suggests that the identity of
the −1 position is not important for spacer selection. Fur-
thermore, alignments of the downstream regions of proto-
spacers on the STSV2 genome did not reveal any further
conserved sequence motifs in agreement with earlier
studies on the Sulfolobales (Lillestøl et al., 2009). Of the
remaining protospacers, seven appear to match spacers
that have been inverted on insertion into the CRISPR loci,
with the PAM sequence located at the leader distal end of
the de novo spacer rather than at the usual leader proximal
end. These seven protospacers are presented together
with the downstream PAM sequences in Table 3. The
remaining six protospacers did not exhibit detectable PAM
sequences.
Resistance of single S. islandicus clones, carrying de
novo STSV2 spacers, to infection by STSV2
Next, single clones were selected and examined further to
establish whether the de novo STSV2 spacers had pro-
duced resistance to viral infection. Five single clones S-1,
S-2, S-4, S-7 and S-23 carrying de novo STSV2 spacers
were chosen (Table 1 and Table S3). PCR amplification of
STSV2 orf145 and SMV1 (positions 33510–35507) dem-
onstrated that none of these clones were still infected,
except S-1 that contained SMV1 (Table 4). Cultures of
these clones, and of the wild-type strain, were then chal-
lenged separately with STSV2, SMV1 and SMV1 + STSV2
and we tested again for the presence of viral DNA by PCR
amplification. STSV2 was not detectable in any of the clone
cultures indicating that each clone was resistant to the
virus. In contrast, SMV1 was present in all of the clones
Table 2. Analysis of the protospacer locations in the STSV2
genome with respect to DNA strand, and coding versus non coding
regions, where the percentage of intergenic DNA was estimated at
11%.
Protospacer locations
Number of
protospacers (%)
Forward strand 56.4
Reverse strand 43.6
Within protein genes 85.7
Coding sequence 43.0
mRNA complement 42.7
Intergenic 14.3
PAM sequences
CCN 95.9
CCA 39.3 (35.5)
CCT 38.4 (35.5)
CCG 11.0 (11.3)
CCC 7.2 (17.7)
Inverted PAM 2.2
No PAM 1.9
A total of 347 de novo spacers were sequenced and analysed, 318 of
which exhibited unique sequences. Percentage values are presented
for the degree of conservation of the CCN PAM sequence. Percent-
age numbers in brackets for the four PAM sequences indicate the
total percentages present in the genome. Inverted PAM indicates that
the PAM sequence is located at the end of the protospacer that
becomes leader distal rather than leader proximal in the CRISPR
locus. No PAM denotes that no CCN sequence was present.
Table 3. Spacer-matching protospacer sequences in the STSV2 genome that are inverted, with the PAM sequence located at the end of the
protospacer that becomes leader distal (bold) rather than leader proximal (underline) in the CRISPR locus.
CRISPR locus STSV2 genome location Protospacer sequence (bordered by triplets)
1 1458–1501 ATTAAAACAATTAATTGATGAGCGTGATGATTTACCAGTCATGAAAATGG
ACC
1 1874–1915 TGCCGCAGGCCCATCGCCGCATTTTACATTATTATTATATTATACGGG
CCC
2 26745–26786 CTTCATCGATGAGTTAAGTAGAGACTACATCATAAAGCCTGTAGCTGG
ACC
2 43235–43277 AAATCACTAACACAATATGGTATGGATCATTGCTGTTAAGTTTATTTGG
ACC
1 61216-61177 (reverse) GTAACAATTACTTTAATGCAATTTTGCAGGTATTCGCTACGTTAGG
TCC
1 65640–65679 ATCAACTATCAGGATGGGTGCCACGAATATTATGATAGAAATAAGG
TCC
1 69890–69928 (reverse) CTCAATAAACGCTCTCAAGCCATCTAGGCTCTTCAACACGAGTGG
ACC
The bold PAM (CCN) sequence is shown on the right hand side on the complementary strand.
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S-1, S-2, S-4 and S-7 except S-23 (Table 4). PCR results
are illustrated for cultures of the representative clones S-7
and S-23 over 30 days p.i and for the control wild-type
strain (Fig. S3A).
Growth curves were prepared for the five clones over a
25 day period and compared with growth curves of unin-
fected and infected wild-type cultures. Each uninfected
clone produced closely similar growth curves but they
grew more slowly than the uninfected wild-type culture as
exemplified for clone S-2 (Fig. 6A). Strong growth retar-
dation was detected for the wild-type culture at the onset
of spacer acquisition suggesting that the process involves
a strong cost for the cells. Total recovery of the growth rate
for the wild-type culture was seen at about 30–35 days p.i.
indicating that several generations are required for full
recovery. Single clones isolated from this culture showed
recovery of the growth rate at about 20 days after isolation
as illustrated for clone S-2 (Fig. 6B). However, when
treated with SMV1 + STSV2, the growth retardation of
each single clone was much less than observed for
the wild-type S. islandicus strain infected with SMV1 +
STSV2 (Fig. 6B).
In summary, the results are consistent with all the
clones, except for S-23, being resistant to re-infection with
STSV2 but not SMV1. Exceptionally S-23 was insensitive
to SMV1 infection, probably due to the development of
non CRISPR-based resistance during the 30 day initial
exposure to the virus. The observed absence of STSV2
was also reinforced by the lack of any additional de novo
STSV2 spacers being detectable by PCR in any of the five
single clones after about 30 days p.i., a time point at which
STSV2 spacer uptake generally occurred in wild-type cul-
tures. This result is also illustrated from clones S-7 and
S-23 (Fig. S3B).
S. islandicus infection with different virus mixtures did
not produce spacer acquisition
Our inability to induce spacer acquisition in S. islandicus
with any single genetic element, including STSV2, raised
the possibility that coinfecting genetic elements are
required to activate spacer uptake. Therefore, new viral
isolates were purified from enrichment cultures that we had
collected from terrestial hot-springs on Iceland and in Italy.
They included a Sulfolobus islandicus filamentus virus 2
(SIFV2) and a Sulfolobus islandicus rod-shaped virus
(SIRV3), both isolated from Iceland and a Sulfolobus short
rod-shaped virus-like particle denoted SSRV from Naples,
Table 4. Single clones of S. islandicus carrying STSV2-derived spacers (Table 1) after challenging with SMV1 and STSV2.
Days p.i. Single clone
STSV2 de novo spacers Infected by Sensitive on reinfection to
Locus 1 Locus 2 SMV1 STSV2 SMV1 STSV2
12 S-1 (29) 1 1 + − + −
20 S-2 (9) 0 1 − − + −
20 S-4 (17) 2 0 − − + −
20 S-7 (7) 2 1 − − + −
30 S-23 (8) 4 7 − − − −
Days p.i – indicates when cells from the culture were plated for isolation of single clones. Infected by – denotes that the virus was still present after
isolation of single clones. Sensitive to – indicates the susceptibility of single clones to infection with SMV1 or STSV2. Sequences and DNA strand
locations of the STSV2 protospacers are listed in Table 1 and Table S3.
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S-2 + STSV2+ SMV1
w.t. + STSV2+ SMV1
Fig. 6. Growth curves of cultures of wild-type S. islandicus and
clone S-2: (A) alone and (B) uninfected and infected with
SMV1 + STSV2, and initiated 12 days p.i.
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Italy. SIFV2 yielded partial genome sequences that
matched closely to the genome of the lipothrixvirus SIFV
(Arnold et al., 2000) and, also, partial sequences of SIRV3
matched closely to the rudiviruses SIRV1 and SIRV2
(Peng et al., 2001). Electron micrographs of the isolated
virus particles are presented in Fig. S4.
The S. islandicus wild-type culture infected with STSV2
was additionally challenged with (a) SIFV2 and (b)
SIRV3 + SSRV, with an uninfected culture as a control.
Growth retardation was observed for each culture carry-
ing virus mixtures 3 days p.i. but growth recovered about
17 days p.i. (Fig. 7A). Mixed virus cultures were main-
tained over 45 days and tested every few days for evi-
dence of spacer acquisition by PCR amplification but
none was detected (Fig. 7B). Infection by STSV2 and
SIFV2 was established by PCR amplification (Table S1),
and infection by SIRV3 and SSRV was confirmed by
electron microscopy (data not shown). We conclude that
infection with a virus mixture could not alone explain the
uptake of de novo STSV2 spacers observed in the pres-
ence of SMV1.
Clone S-1 rapidly acquired spacers from SMV1 after
storage at −80°C
Clone S-1 originated from a culture that was actively
acquiring de novo STSV2 spacers 12 days p.i. It was still
infected with SMV1 but had lost STSV2 and carried a
single de novo STSV2 spacers in each CRISPR locus
(Table S3). Initially, it was selected for further study to
determine whether it is able to acquire de novo spacers
from different viruses. When cultured from a glycerol stock
at −80°C, growth of S-1 was strongly retarded and, con-
sistent with the preceding results, it could not be rein-
fected with STSV2. Unexpectedly, PCR amplification
results of the leader adjacent regions indicated that
spacer uptake had occurred exceptionally rapidly, already
2 days p.i. (Fig. 8A).
The de novo spacers in both CRISPR loci were
sequenced and, surprisingly, they all matched to SMV1.
Forty three unique de novo spacers were sequenced and
they are superimposed on the genome map of the SMV1
virus (Fig. 4). This indicated that either SMV1 had lost its
ability to protect itself against spacer acquisition or that
mutations had occurred in the host enabling it to circum-
vent the underlying viral protection mechanism. We con-
cluded that the cold-shock treatment had rendered SMV1
susceptible to spacer acquisition.
Differential loss of de novo SMV1 and STSV2 spacers
Viral infection of the SMV1-infected S-1 culture was moni-
tored over a 27 day period and we also examined the de
novo spacer composition of both CRISPR loci. The results
showed that SMV1 was propagating stably despite the
presence of de novo SMV1 spacers (Fig. 8). However, a
significant difference was observed in the CRISPR loci at
about 21 days after reactivation of the culture in that both
de novo SMV1 spacers were lost. Furthermore, about 27
days after reactivation both de novo STSV2 spacers were
also lost and the CRISPR loci had reverted to the wild-
type composition (Fig. 8A). This difference was confirmed
for several single clones isolated from this culture
B
A
Dpi6 Dpi30Dpi15
A
60
0
A
60
0
Time [h]
Time [h]
Dpi45C
Fig. 7. Effect of multiple viral infections on growth rates and the
CRISPR loci of wild-type S. islandicus.
A. Growth curves of uninfected S. islandicus cultures and cultures
infected with STSV2 + SIFV2 or with STSV2 + SIRV3 + SSRV that
were measured 4–7 days, and 17–20 days p.i. Electron
micrographs of SIFV2, SIRV3 and SSRV virus particles are
presented in Fig. S4.
B. PCR-amplified products from the leader proximal regions of
CRISPR locus 1 of S. islandicus infected with each virus mixture,
and from an uninfected S. islandicus control (C). Samples were
analysed over 45 days p.i. Dpi, days post infection.
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(Table 5) and it was concluded that all the de novo
spacers were reversibly lost in the SMV1-infected S-1
culture. Moreover, de novo spacer uptake and loss coin-
cided with strongly retarded growth over the whole 27 day
period and these results were reproducible in two inde-
pendent experiments.
Infection with SIFV2 influenced SMV1 propagation
Next we examined whether SMV1 could induce spacer
acquisition from the coinfecting filamentous virus SIFV2 by
challenging the SMV1-infected S-1 culture with SIFV2 and
testing for spacer acquisition over 27 days. We compared
Dpi6 Dpi12 Dpi21 Dpi24 Dpi27
A
B
SMV1
SMV1+SIFV2
culture
Dpi2 Dpi9 Dpi15 Dpi18
culture Dpi6 Dpi12 Dpi21 Dpi24 Dpi27Dpi2 Dpi9 Dpi15 Dpi18
C
culture Dpi6 Dpi12 Dpi21 Dpi24 Dpi27Dpi2 Dpi9 Dpi15 Dpi18
SMV1
SMV1+SIFV2
SMV1+SIFV2
D
S-1B
Dpi6 Dpi12Dpi9 Dpi15
C
C
C
C
Fig. 8. PCR analyses of CRISPR loci and viral DNA in SMV1-infected clone S-1, the latter culture challenged with SIFV2, and the
SMV1-reinfected subclone S-1B.
A. PCR-amplified products from the leader proximal region of CRISPR locus 1 of SMV1-infected clone S-1 before, and after, infection with
SIFV2 compared with the PCR product from the uninfected S. islandicus control (C).
B. PCR-amplified products from SMV1 in cultures with and without SIFV2 in (A) and from an isolated SMV1 control (C).
C. PCR-amplified products from SIFV2 in the S-1 culture coinfected with SIFV2 and from a purified SIFV2 control (C).
D. PCR-amplified products from the leader proximal region of CRISPR locus 1 for the S-1B subclone infected with a mixture of
SMV1v + SMV1 isolated from clone S-1 and an uninfected control sample (C). In each experiment template DNA concentrations were
adjusted to be the same for each sample. Dpi, days post infection.
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the CRISPR loci of the control SMV1-infected S-1 culture
and after challenging it with SIFV2. The latter culture
was shown by PCR amplification to be infected by both
SMV1 and SIFV2 (Fig. 8B and C) but, unexpectedly, after
the initial spacer acquisition, the CRISPR loci remained
unchanged over the whole 27 day period. This contrasted
with the loss of all de novo spacers observed for the
SMV1-infected S-1 control culture (Fig. 8A). Sequencing
of the de novo spacers in the SIFV2-infected culture at 3
and 21 days p.i. revealed only SMV1-matching spacers
and none from SIFV2. The results suggested that acquisi-
tion of de novo SMV1 spacers occurred prior to SIFV2
infection but that coinfection with SIFV2 influenced propa-
gation of SMV1 because, in contrast to the control culture
lacking SIFV2, no loss of de novo spacers occurred
(Fig. 8A). Furthermore, subclones carrying de novo SMV1
spacers could be isolated from the SIFV2-infected culture
(Table 5).
Complex relationship between de novo spacer
composition and SMV1, STSV2 and SIFV2 sensitivity
of different S-1 subclones
Next we tested whether the de novo SMV1 spacers gen-
erated resistance to SMV1 infection. Single clones were
isolated from the SMV1-infected S-1 cultures and leader
proximal regions of the CRISPR loci of several clones
were sequenced and shown to have reverted to wild-type
spacer compositions (Fig. 8A). A single subclone S-1A
was then selected for further characterization. Two sub-
clones, S-1B and S-1C, with de novo SMV1 spacers,
were selected from the SMV1+SIFV2-infected S-1 culture.
PCR amplification demonstrated further that none of the
three subclones contained SMV1, but S-1C was still
infected with SIFV2 (Table 5). The three subclones were
then tested for sensitivity to reinfection with both STSV2
and SMV1 isolated from the S-1 culture. Only S-1A was
reinfected by STSV2, consistent with the loss of de novo
STSV2 spacers, but unexpectedly it was resistant to
SMV1 (Table 5). We infer that cells had developed SMV1
resistance by a CRISPR-independent mechanism, as was
observed for clone S-23 isolated from an STSV2 + SMV1-
infected wild-type culture (Table 4).
The resistance of S-1B to STSV2 reinfection was con-
sistent with the presence of de novo STSV2 spacers but
it was sensitive to SMV1 infection despite the presence of
de novo SMV1 spacers. In contrast, S-1C was resistant to
both STSV2 and SMV1 infections, consistent with SIFV2
affecting SMV1 propagation (Table 5). Furthermore, sub-
clone S-1B differed from the subclone S-1C in that the de
novo SMV1 spacers were also gradually lost (Fig. 8D).
We concluded that the CRISPR loci of S-1C were stable
because the subclone was not infected by SMV1.
A variant SMV1, SMV1v, with an altered response
to the CRISPR immune system is deficient in a
virion protein
We investigated further the S-1 clone carrying de novo
SMV1 spacers with a view to understand how SMV1
avoids the CRISPR immune system. PCR amplification of
continuous contigs along both host CRISPR loci revealed
no size changes (data not shown). Therefore, we ana-
lysed virus particles released from S-1 cells for altered
properties. No morphological changes were observed in
electron micrographs and no evidence of viral DNA modi-
fication was observed with multiple restriction enzyme
digests which all produced digestion patterns identical to
those of wild-type SMV1 DNA (Fig. S1B). However, when
SMV1 was isolated from S-1 and purified by standard
CsCl density gradient centrifugation, exceptionally two
closely migrating virion bands were resolved. Both prod-
ucts were analysed for protein content by SDS-PAGE and
virions from the lower band lacked a small protein com-
ponent that was present in both the upper band and
wild-type SMV1 virions (Fig. 9A). The latter virus was
named SMV1 variant, SMV1v, and the deficient protein
was purified from the wild-type SMV1 and subjected to
Edman N-terminal sequencing. It carried the N-terminal
sequence VDEYF which constituted a truncated version
Table 5. Characterization of subclones isolated from S-1 cultures that carried single de novo STSV2 spacers in each CRISPR locus (Table 4).
Parent culture
Single
clone
STSV2
infected
SMV1
infected
SIFV2
infected
Locus 1 de novo
spacers
Locus 2 de novo
spacers
STSV2
sensitive
SMV1
sensitiveSTSV2 SMV1 STSV2 SMV1
S-1 S-1A − − − 0 0 0 0 + −
S-1 + SIFV2 S-1B − − − 1 2 1 2 − +
S-1C − − + 1 0 1 5 − −
The cultures were either uninfected or infected with SIFV2. Each subclone was tested for the presence of STSV2, SMV1 and SIFV2 and the de
novo spacers of each subclone were PCR amplified and sequenced. 0 indicates that no de novo spacers were present. Each subclone was also
tested for sensitivity to reinfection by STSV2, and by the SMV1 mixture isolated from S-1. ‘+’ and ‘−’ denote positive and negative results
respectively.
910 S. Erdmann, S. Le Moine Bauer and R. A. Garrett ■
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 91, 900–917
of ORF153, a putative protein showing significant
sequence similarity to the virion proteins ORF131 of
ATV and ORF145 of STSV2 (Table S2). The protein con-
tains 114 amino acids, lacking the N-terminal 39 amino
acids of ORF153, and it exhibits the potential start codon
GUG.
Evidence supporting that SMV1v DNA is susceptible to
spacer acquisition
Next, we tested the hypothesis that SMV1v DNA is sensi-
tive to spacer acquisition and challenged wild-type
S. islandicus with an approximately equal mixture of SMV1
and SMV1v isolated from clone S-1. An additional culture
infected with the SMV1 virus mixture + STSV2 was tested
as a control. Infection produced immediate growth retar-
dation in both cultures, much earlier than normally
observed during the initial SMV1 infections at 12 days
p.i. (Fig. 2A). Moreover, the de novo spacer uptake had
occurred in both CRISPR loci 3 days p.i., as judged from
the formation of larger PCR products but the reaction
ceased at about 6 days p.i. after which larger PCR product
yields decreased (Fig. 9B). These larger PCR products
were cloned and sequenced and the de novo spacer
sequences matched DNA from either SMV1 or the host
S. islandicus, with 10 of the 12 unique spacer sequences
matching the host chromosome.
Furthermore, the culture challenged with the SMV1 +
SMV1v mixture + STSV2 produced a second growth retar-
dation at 12 days p.i and uptake of multiple de novo
spacers per CRISPR locus was observed exclusively from
STSV2 (Fig. 9B) as seen earlier for SMV1 + STSV2-in-
fected cells (Fig. 2A). We infer that the initial de novo SMV1
spacers are produced from SMV1v while the subsequent
uptake of STSV2 spacers is induced by SMV1.
Next S. islandicus was challenged with the SMV1v +
SMV1 mixture and the rudivirus SIRV3 (Fig. S4). Spacer
acquisition was observed from both SMV1 and SIRV3 DNA
about 3 days p.i. again consistent with the SMV1v inducing
spacer acquisition immediately after infection (data not
shown). This also established that SMV1 can facilitate
spacer acquisition from a second virus carrying a linear
genome that did not activate spacer acquisition when
infected with other viruses (Fig. 7A and B).
ORF114 binds DNA cooperatively
ORF114 was absent from the SMV1v virions that had
apparently lost the ability to avoid spacer acquisition. The
secondary structure prediction for ORF114 revealed a
helix–turn–helix motif and the overall protein prediction
was similar to the structure determined for the homolo-
gous ATV virion protein ORF131 and the virion protein
ORF145 of STSV2 (Goulet et al., 2010; Erdmann et al.,
2014). To examine the properties of the protein further, the
gene was cloned into vectors producing either a
C-terminal His6-tag or an N-terminal GST-tag and it was
expressed recombinantly in E. coli. The purified protein
was shown to be contaminated with E. coli DNA, that was
difficult to remove, consistent with DNA-binding activity.
DNA-binding assays were performed with ORF114-His6
on a 125 bp DNA-substrate and the resulting binding
curve was consistent with cooperative binding of multiple
copies of ORF114 per DNA fragment (Fig. 10A). We infer
that the high protein : DNA molar ratio at the plateau
reflects firstly that multiple protein copies are bound per
DNA molecule and secondly that many protein molecules
SMV1v
SMV1 
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Locus
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Fig. 9. Isolation of the SMV1v from SMV1-infected clone S-1.
A. 11% SDS-PAGE of CsCl gradient-purified virus particles. Two
closely migrating SMV1 bands were resolved in the gradient. The
lower band lacked the small encircled protein component that was
present in the upper band and wild-type SMV1.
B. PCR amplified products from the leader proximal region of
CRISPR locus 1 of wild-type S. islandicus infected with the
SMV1v + SMV1 mixture and STSV2. Larger PCR products that
were visible for both CRISPR loci at 3 days p.i. are encircled.
Control (C) – uninfected S. islandicus.
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were not displaced from E. coli DNA fragments during
preparation.
Next, triplicate pull-down assays were performed with
GST-ORF114 immobilized on Glutathione Sepharose and
free ORF114-His6 showing no evidence of interaction.
This suggests that ORF114 does not oligomerize like the
homologue ORF145 in STSV2 (Erdmann et al., 2014) and
it supports the observation of cooperative DNA binding
(Fig. 10A).
SMV1 DNA replication is induced by cold-shock of
infected cultures
Earlier we demonstrated that when a S. solfataricus
culture was infected with a mixture of SMV1 and pMGB1
and subjected to cold-shock by freezing at −80°C, de
novo spacer uptake from pMGB1 was specifically acti-
vated for one of six CRISPR loci (locus A) (Erdmann et al.,
2013). Moreover, in this study clone S-1 showed unex-
pected spacer acquisition from SMV1 on infection with
SMV1 after storage at −80°C. Therefore, we investigated
whether cold stress influenced viral replication by sam-
pling an SMV1 + STSV2-infected culture 2 days p.i.,
storing the cells overnight in 15% glycerol at −80°C and
reactivating the culture after 12 h. The original culture,
and the cold-shocked culture, were then sampled each
day, and DNA was extracted and diluted to the same
concentration for each sample. The results showed that
STSV2 DNA was present at a high level in both cultures
consistent with the virus actively replicating. In contrast,
SMV1 DNA was present at a very low concentration in the
untreated culture but it increased strongly in yield after
cold-shock, consistent with the cold-shock activating
SMV1 replication (Fig. S5).
Discussion
SMV1 activates spacer acquisition indirectly from
coinfecting genetic elements
Evidence is presented demonstrating that when the
single-tailed fusiform viruses SMV1 and STSV2 coinfect
S. islandicus REY15A, hyperactive spacer acquisition
occurs exclusively from STSV2 in both CRISPR loci. In
contrast, neither STSV2 alone, nor multiple infections
with diverse linear DNA Sulfolobus viruses, nor mixtures of
both STSV2 and linear DNA viruses, stimulated detectable
spacer acquisition. Spacer uptake was also observed
earlier from a conjugative plasmid pMGB1 that was coin-
fected with SMV1 in S. solfataricus P2 (Erdmann and
Garrett, 2012) but neither study showed spacer acquisition
from SMV1. This indicated that SMV1 was protected
against spacer acquisition and therefore we infer that the
spacer uptake from co-infecting viruses is a secondary
effect induced by, but not directed by, SMV1.
SMV1 infection of S. islandicus alone resulted in cell
death (Fig. 3A) and, given that SMV1 does not cause cell
lysis, and that no coinfecting genetic elements were
present, this may have been caused by spacer uptake
from, and DNA interference of, chromosomal DNA. This
interpretation is strengthened by the observation that
there was a preferential uptake of spacers from the
S. islandicus chromosome only three days after infection
of the wild-type strain with SMV1v.
A
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GST GST-ORF114
ORF114-His6 ORF114-His6
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bound DNA
Fig. 10. Biochemical characterization of
ORF114.
A. DNA binding assay with increasing
concentrations of ORF114 (6.25–200 pmol)
and 0.35 pmol of 32P-labelled 125 bp dsDNA
substrate in tracks from left to right, 0 (control
sample C), 18:1, 36:1, 72:1, 90:1, 144:1,
216:1, 288:1 and 567:1 protein : DNA molar
ratios.
B. Pulldown assay of GST-ORF114 with
ORF114-His6 with GST serving as control. P
denotes the pellet (beads with immobilized
protein) and S indicates supernatant (free
protein after incubation with beads).
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Spacer acquisition is associated with strong growth
retardation of the culture
Culture growth was strongly retarded during spacer acqui-
sition on SMV1-infection of S. islandicus, and also of
S. solfataricus (Erdmann and Garrett, 2012). The growth
rate recovered about 20 days after acquisition was initi-
ated. Moreover, single clones isolated from a culture
undergoing spacer acquisition, that had lost the virus, still
showed retarded growth for about 12 days after isolation
(Fig. 6), indicating that growth retardation was not only
caused by viral infection. Spacer acquisition and viral
replication seems to produce a high cost for the cells.
However, the adaptation process could be facilitated by
toxin activity which would cause a decrease in cell growth
and could provide a window for spacer uptake to occur
prior to cell division, because several generations were
required in our study for reestablishing growth rates after
termination of spacer acquisition. Toxin-antitoxin gene
pairs are often interwoven among cas gene cassettes and
it has also been proposed that some Cas proteins may
exhibit toxin activities (Garrett et al., 2011; Makarova
et al., 2012).
Essentially random protospacer selection
318 unique de novo spacer sequences were determined
and superimposed on the STSV2 genome. Their distribu-
tion is essentially random with respect to the DNA strand
and to protein coding versus non coding regions, following
the pattern described recently, for spacer acquisition from
the Sulfolobus conjugative plasmid pMGB1 (Erdmann and
Garrett, 2012; Erdmann et al., 2013), and in agreement
with earlier in silico predicted distributions of protospacers
localized on linear and circular genomes of diverse genetic
elements of the Sulfolobales (Shah et al., 2009; 2011;
Shah and Garrett, 2011). This is in marked contrast to the
recent demonstration of biased protospacer selection from
a bacteriophage by a bacteria-specific subtype II-A
CRISPR system of S. thermophilus (Paez-Espino et al.,
2013). Another significant difference from bacterial
systems is that no evidence was found for the same DNA
strand directionality of de novo spacers taken up consecu-
tively in a given CRISPR locus, as reported for a genetically
manipulated E. coli subtype I-E spacer acquisition
(Datsenko et al., 2012; Swarts et al., 2012).
Limits on CRISPR locus sizes
Hyperactive spacer acquisition occurred in both CRISPR
loci of S. islandicus, with a maximum of 5 new spacers in
locus 1 and 8 in locus 2 and these maxima were not
exceeded despite spacer uptake continuing over many
days. This suggests that there is a mechanism regulating
the maximum length of a CRISPR locus. In support of this,
maximum limits on the numbers of acquired de novo
pMGB1 spacers were observed for loci C, D and E of
S. solfataricus (Erdmann and Garrett, 2012).
All de novo STSV2 spacers generated viral resistance
Experiments with several isolated single clones carrying
different de novo STSV2 spacers provided evidence for
the degree of viral resistance not being influenced by the
number, or sequence, of the de novo STSV2 spacers
present. This differs from the earlier observation of
increasing numbers of de novo spacers providing
increased bacteriophage resistance for the type II-A
CRISPR system of S. thermophilus (Barrangou et al.,
2007; Deveau et al., 2008).
The 27 unique single clones from S. islandicus carried
a wide range of numbers of de novo spacers extending
from one (S-2, S-3, S-11) and two (S-1, S-4, S-5, S-6, S-9)
up to ten (S-26), eleven (S-23) and twelve (S-27)
(Table 1). All were completely resistant to infection with
STSV2. This suggests that the virus can only escape DNA
interference by undergoing protospacer mutations or
deletions such that multiple de novo spacers will give the
host added protection over longer periods.
Evidence for reversible uptake of CRISPR spacers
The progressive loss of de novo STSV2 and SMV1
spacers observed for clone S-1 and subclone S-1B
(Fig. 8A) reinforces that de novo spacers are potentially
less stable than older spacers since a deletion of internal
CRISPR spacers was shown to be a rare event. This loss
of de novo spacers was only observed when SMV1v was
present but not for single clones infected only with SMV1 or
for single clones that were resistant to SMV1 infection.
Therefore, we infer that loss of de novo spacers is induced,
directly or indirectly, by the SMV1 variant. It was demon-
strated earlier that plasmids carrying protospacers match-
ing host spacers of S. solfataricus P2 or S. islandicus
REY15A could survive DNA interference when matching
spacers in the CRISPR loci were deleted (Gudbergsdottir
et al., 2011). Thus, spacer loss observed in S. islandicus
could result from a reversible spacer acquisition mecha-
nism, possibly induced by the SMV1 variant.
Inter-viral conflicts between SMV1 and SIFV2
Contrasting spacer acquisition results were obtained for
S. islandicus cultures infected with SMV1 alone or with
SMV1 + STSV2. Clone S-1 carrying de novo STSV2
spacers lost these spacers. However, when the same
culture was challenged with SIFV2, no spacer loss
occurred. Given that spacer loss only occurred in the
presence of SMV1v, the result indicates that this variant
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was unable to reinfect SIFV2-infected cells. Moreover, a
subclone S-1C isolated from this SIFV2-infected culture
that was still infected with SIFV2, was shown to be insen-
sitive to SMV1 infection. Therefore we infer that intracel-
lular SIFV2 can inhibit coinfection by SMV1.
Conflicting interactions between SMV1 and the CRISPR
immune system: a working hypothesis
SMV1 activates spacer acquisition: a link between viral
DNA replication and spacer acquisition. The activation
mechanism for spacer acquisition remains unclear. There
was no evidence for the operation of a matching spacer
‘priming’ mechanism (Table 1 and Table S3) as proposed
for a bacterial type I-E system (Datsenko et al., 2012),
unless it can occur indirectly, where the CRISPR spacers
matching SMV1 can act as ‘primers’ for spacer uptake
from a second genetic element. Nor was there evidence
for the successive uptake of de novo spacers, deriving
from one DNA strand, in a given CRISPR locus (Table 1).
However, our experimental results did suggest a link
between spacer acquisition and viral DNA replication. On
coinfection with STSV2 + SMV1, STSV2 replicated imme-
diately on infection, whereas SMV1 replication was only
detectable 12–16 days later, or 2 to 3 days later after
exposure to freezing at −80°C (Fig. S5). Consistent with
this inference, SMV1 replication was observed immedi-
ately after infecting an S. solfataricus P2 mutant lacking
both CRISPR loci A to D and cas genes required for
spacer acquisition (Erdmann and Garrett, 2012).
STSV2 alone did not activate spacer acquisition but,
unlike SMV1, it exhibits a modified genome (Erdmann
et al., 2014) which might enable the viral DNA to avoid
being recognized as an invading genetic element. Thus,
although SMV1 initially remains dormant in cells carrying
active CRISPR systems for self-protection, host cell
ageing, cold-shock, or other stress factors, seem to stimu-
late SMV1 replication which results in activation of the
CRISPR immune system and spacer acquisition.
SMV1 resistance to spacer acquisition: viral DNA is
protected by a protein. No spacer acquisition from SMV1
was detected after coinfection of S. solfataricus with
SMV1 + pMGB1 (Erdmann and Garrett, 2012) nor after
coinfection of S. islandicus with SMV1 + STSV2 (this
study) which indicates that SMV1 is protected against
protospacer selection. Exceptionally, SMV1 DNA from
clone S-1 was sensitive to spacer acquisition. Analysis of
the infecting virions revealed two distinct particles one
lacking ORF114 which was subsequently shown to bind
DNA cooperatively. Assuming that SMV1 DNA carries
some bound ORF114 during replication, and that ORF114
binds cooperatively, it will always preferentially assemble
on the SMV1 genome and could, thereby, physically
protect SMV1 DNA from protospacer selection. Thus the
SMV1v virion could result from the rapid viral DNA repli-
cation that follows cold shock of host cells at −80°C and
results in a deficient production of ORF114.
SMV1 avoids CRISPR-directed DNA interference: indi-
rectly, and directly? On infecting S. islandicus, both
SMV1 and the SMV1v + SMV1 mixture avoided DNA
interference despite a spacer with a single mismatch
encoded by S. islandicus and de novo SMV1 spacers
present in subclone S-1B, each with an associated
cognate -CCN- PAM sequence. SMV1 also infected
S. solfataricus P2 despite the presence of eight perfectly
matching spacers with cognate PAM sequences
(Erdmann and Garrett, 2012). Therefore, we infer that
both SMV1 and SMV1v are able to avoid CRISPR-
directed DNA interference although the mechanism
remains unclear.
SMV1 appears to be dormant in cells with active
CRISPR systems for 12–14 days p.i., although not in
CRISPR-deficient mutants (Erdmann and Garrett, 2012),
possibly to protect itself from DNA interference. Thus, as
suggested for activation of spacer acquisition, DNA inter-
ference might also be activated by the onset of viral repli-
cation. Non replicating SMV1 could provide a limited period
for viral protein biosynthesis.Although a role for ORF114 in
avoiding DNA interference can be excluded, because
SMV1v is able to infect wild-type S. islandicus or S-1
subclone S-1B carrying matching SMV1 spacers (Table 5),
other viral proteins may be expressed which directly inhibit
the interference complex or indirectly protect the viral DNA
from the interference complex, possibly in a related way to
anti-CRISPR viral proteins described for some Pseu-
domonas strains (Bondy-Denomy et al., 2012).
Perspectives
Phylogenetically diverse archaeal viruses have been
shown to coinfect hosts in natural environments and
under laboratory conditions (Prangishvili and Garrett,
2005). The experiments described here with the different
viruses SMV1, STSV2, SIFV2 and SIRV3 infecting Sul-
folobus show that interactions with the host CRISPR
system can be very complex, and complicated further by
the potential activation of other resistance mechanisms
observed for some clones. This raises many unresolved
questions including why does STSV2 not activate spacer
acquisition although it is sensitive to DNA interference,
and how does SIFV2 inhibit infection of S. islandicus
with SMV1? Clearly, each virus has evolved its own
mechanisms for virus-host interactions, and for coexisting
intracellularly with other genetic elements. Continuous
infections with different viruses produce diverse reactions
from both virus and host as observed, for example, for
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both the variant virus SMV1v and the different clones
isolated from virus-infected S. islandicus cultures. This
work yields insights into the conflicting interactions of
SMV1 with the host CRISPR immune system of S. islandi-
cus and we propose potential mechanisms for the viral
resistance to spacer acquisition and DNA interference.
Clearly further studies will be required to elucidate the
complex mechanistic details of these diverse interactions.
Experimental procedures
Infection, isolation and sequencing of the SMV1
viral genome
S. islandicus REY15A was grown in Sulfolobus medium sup-
plemented with 0.2% trypton, 0.1% yeast extract and 0.2%
sucrose (TYS medium) (Zillig et al., 1994). 10 ml of cells were
harvested from a fresh culture by centrifuging (6000 g,
10 min) and resuspending in 1 ml of TYS medium. A virus
mixture from Yellowstone National Park, USA, was isolated
(Erdmann and Garrett, 2012) and 20 μl were added. After
incubating for 2 h at 78°C, infected cells were transferred to
50 ml of pre-heated (78°C) TYS medium. The culture was
then incubated for 3 to 6 days at 78°C before isolating and
purifying the virus (Erdmann and Garrett, 2012). The viral
genome was sequenced using a Hiseq 2000 sequenator
(Beijing Genomics Institute, Shenzhen, China) to yield about
a 200-fold coverage and the genome was assembled using
the CLC genome package (Aalborg, Denmark) and Velvet
(Zerbino and Birney, 2008). Gaps between assembled
contigs where closed by PCR amplification and sequencing.
Isolation of SIFV2, SIRV3 and SSRV and infection of
S. islandicus
SIFV2 and SSRV were isolated from a mud sample taken
from the Gunnuhver geothermal area, Iceland and SIRV3
was isolated from a mud sample collected at Pozzuoli,
Naples, Italy. Isolation was performed as described for SMV1
using S. islandicus REY15A as host strain (Erdmann and
Garrett, 2012). Virus particles were purified by loading onto
0.45 g ml−1 CsCl and centrifuging at 38 000 rpm for 48 h in a
SW41 rotor (Beckman, Fullerton, USA). Virus bands were
extracted and CsCl was removed by dialysis against 10 mM
Tris-HCl, pH 8. DNA was isolated from purified virus particles
using DNeasy® Blood&Tissue Kit (Qiagen, Westberg,
Germany) and digested with HindIII (Fermentas, St. Leon-
Rot, Germany). Ends were filled in using Klenow Polymerase
(Fermentas) according to the manufacturer’s protocol. Blunt
end fragments were cloned using CloneJET PCR Cloning Kit
(Thermo Fisher Scientific) and sequenced (MWG Eurofins,
Ebersberg, Germany). Contigs were used for primer design
to verify infection by PCR. 10 ml of S. islandicus cells were
harvested from a fresh culture by centrifuging (6000 g,
10 min) and resuspending in 1 ml of TYS medium. Three
microlitres of each purified virus, SMV1 SIFV2 or SIRV3 at
50 PFU μl−1 and 22.5 × 106 particles μl−1 of STSV2 were
added and, after incubating for 2 h at 80°C, infected cells
were transferred to 50 ml of pre-heated TYS medium at 78°C.
Infection with SSRV was achieved in the same manner using
an environmental virus mixture containing SSRV that was
isolated as described (Erdmann and Garrett, 2012) together
with an additional virus-like particle that did not propagate in
S. islandicus REY15A.
Growth curves and PCR amplification of CRISPR loci
and viral genomes
Wild-type S. islandicus REY15A and isolated single clones
were cultivated in 50 ml TYS medium at 78°C, both unin-
fected and after infection with different viruses. One millilitre
was taken from each culture every 12 h and A600 values were
measured. In addition, 2 ml samples were extracted every
24 h and cells were harvested by centrifugation (6000 g,
10 min) and DNA was isolated using DNeasy® Blood&Tissue
Kit (Qiagen). Infection with SMV1, STSV2 and SIFV2 was
monitored by PCR amplification using primers listed in
Table S1. Infection with SSRV and SIRV3 was monitored by
electron microscopy. Leader proximal regions of CRISPR
loci 1 and 2, extending from the leader to spacer five, and
approximately 750 bp regions covering the whole of each
CRISPR locus, were amplified by PCR using the listed
primers (Table S1). The template DNA concentration was
measured using NanoDrop 1000 (Thermo Fisher Scientific)
and each sample was adjusted to the same concentration.
Cloning and sequencing of CRISPR products
PCR products were separated on 1% agarose gels and
bands larger than those produced from the uninfected control
sample were excised from gels and purified with QIAquick
Gel Extraction Kit (Qiagen). The PCR products were then
cloned using InsTAclone™ PCR Cloning Kit (Thermo Fisher
Scientific) following the manufacturer’s protocol. Plasmid
purification and sequencing were performed by GATC
Biotech AG (Konstanz, Germany).
Transmission electron microscopy
Virus particles were adsorbed onto carbon-coated copper
grids for 5 min and stained with 2% uranyl acetate. Images
were recorded using a Tecnai G2 transmission electron
microscope (FEI, Eindhoven, the Netherlands), with a CCD
camera, at an acceleration voltage of 120 kV.
Identification of viral protein ORF114
Purified virus particles were dissolved in loading buffer,
25 mM Tris-HCl, pH 8.0, 12.5% glycerol, 50 mM DTT, 0.01%
bromophenol blue, 2.5% SDS, heated at 95°C for 5 min, and
electrophoresed in an 15% polyacrylamide gel with 0.1%
SDS. The resolved protein bands were blotted onto a PVDF
membrane (Millipore, Billerica, USA) and the membrane was
stained with Ponceau red. The protein band corresponding to
ORF114 was excised and identified by N-terminal Edmann
sequencing (Alphalyse, Odense, Denmark).
Purification of ORF114 and DNA binding studies
The ORF114 gene was amplified by PCR from DNA isolated
from purified SMV1 particles and cloned into pET28d
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(Erdmann et al., 2013). The ORF114 forward primer, 5′-
ACGGAATTCATGGTGGATGAGTATTTC-3′ carried an addi-
tional EcoRI restriction site. The reverse primer 5′-GC
TCTCGAGACATTGATAAGCCATCTG-3′ contained an XhoI
restriction site that was used for cloning. The GST fusion
construct of ORF114 was generated using forward
primer 5′-ACGGAATTCACATGGTGGATGAGTATTTC-3′ and
reverse primer 5′-GCTCTCGAGATTATTGATAAGCCATCTG-
3′. The PCR product was cleaved with EcoRI and XhoI and
ligated into the linearized pGEX6P-2 vector. Expression and
purification of ORF114 and pull-down experiments were per-
formed as described (Erdmann et al., 2014). DNA binding
experiments were performed for 30 min at 50°C in 50 mM
NaH2PO4, pH 6.4 containing 150 mM KCl, 2.5 mM MgCl and
1% glycerol. The DNA substrate was generated by PCR using
forward primer 5′-ATAAACAGCTGTCCTATCC-3′ and reverse
primer 5′-TCTTCAAGAATGAGCAAAC-3′ from a genomic
library of the Acidianus two-tailed virus (Häring et al., 2005). It
was 5′ end-labelled using 32P-ATP (Perkin Elmer, Waltham,
USA) and T4 polynucleotide kinase (Thermo Fisher Scientific).
Protein-bound and free DNA were separated in an non dena-
turing 9% polyacrylamide gel and DNA bands were visualized
autoradiographically.
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